Literature DB >> 7676172

The effect of sleep apnea on plasma and urinary catecholamines.

J E Dimsdale1, T Coy, M G Ziegler, S Ancoli-Israel, J Clausen.   

Abstract

Numerous studies have suggested an alteration of sympathetic nervous system functioning in sleep apnea. However, most of these studies did not control for confounding factors such as diet, obesity, hypertension and anti-hypertensive medications. We examined plasma and urinary catecholamines in 43 patients, including hypertensive and normotensive individuals with and without sleep apnea. Hypertensive patients were studied at least 3 weeks following tapering of anti-hypertensive medication. All patients consumed similar diets and were of similar age and level of obesity. Twenty-four-hour urinary norepinephrine levels were significantly higher in apneics (58.2 ng vs. 40.2 ng in nonapneics, p < 0.002). Urinary norepinephrine in apneics was increased during both day and night. Plasma norepinephrine levels were not significantly elevated in apneic patients but were elevated in hypertensive patients both during sleep and in the morning (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676172

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  37 in total

1.  Improving Heart rate variability in sleep apnea patients: differences in treatment with auto-titrating positive airway pressure (APAP) versus conventional CPAP.

Authors:  Levent Karasulu; Pinar Ozkan Epöztürk; Sinem Nedime Sökücü; Levent Dalar; Sedat Altin
Journal:  Lung       Date:  2010-04-07       Impact factor: 2.584

2.  Rapid reduction of antihypertensive medications and insulin requirements after tracheostomy in a patient with severe obstructive sleep apnea syndrome.

Authors:  Arvind Bhimaraj; Navasuma Havaligi; Siva Ramachandran
Journal:  J Clin Sleep Med       Date:  2007-04-15       Impact factor: 4.062

3.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

4.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

5.  SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  Sleep Med Clin       Date:  2007-06

Review 6.  The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea.

Authors:  Valeria Bisogni; Martino F Pengo; Giuseppe Maiolino; Gian Paolo Rossi
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

7.  Resistant hypertension and obstructive sleep apnea in the setting of kidney disease.

Authors:  Khaled Abdel-Kader; Sheena Dohar; Nirav Shah; Manisha Jhamb; Steven E Reis; Patrick Strollo; Daniel Buysse; Mark L Unruh
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

8.  Platypnea-orthodeoxia syndrome due to patent foramen ovale. An unusual cause of Cheyne-Stokes respiration.

Authors:  T Bitter; L Faber; W Scholz; H Fox; C Prinz; D Horstkotte; O Oldenburg
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

9.  Central serous chorioretinopathy and risk for obstructive sleep apnea.

Authors:  Thellea K Leveque; Le Yu; David C Musch; Ronald D Chervin; David N Zacks
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

10.  Sleep-related changes in autonomic control in obstructive sleep apnea: a model-based perspective.

Authors:  Michael C K Khoo; Anna Blasi
Journal:  Respir Physiol Neurobiol       Date:  2013-05-23       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.